29 related articles for article (PubMed ID: 24982)
1. Fluphenazine decanoate (depot) and enanthate for schizophrenia.
Maayan N; Quraishi SN; David A; Jayaswal A; Eisenbruch M; Rathbone J; Asher R; Adams CE
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD000307. PubMed ID: 25654768
[TBL] [Abstract][Full Text] [Related]
2. Depot pipotiazine palmitate and undecylenate for schizophrenia.
Dinesh M; David A; Quraishi SN
Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD001720. PubMed ID: 15495016
[TBL] [Abstract][Full Text] [Related]
3. Three years' maintenance neuroleptic treatment in schizophrenia--before and beyond.
Dencker SJ; Frankenberg K; Lepp M; Lindberg D; Malm U
Acta Psychiatr Scand; 1978 Feb; 57(2):103-14. PubMed ID: 24981
[TBL] [Abstract][Full Text] [Related]
4. Standard and long-acting depot neuroleptics in chronic schizophrenics: an 18-month open multicentric study.
Simon P; Fermanian J; Ginestet D; Goujet MA; Péron-Magnan P
Arch Gen Psychiatry; 1978 Jul; 35(7):893-7. PubMed ID: 28102
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial].
Woggon B; Dick P; Fleischhauer HJ; Gmür M; Gruber G; Angst J; Heimann H
Int Pharmacopsychiatry; 1977; 12(4):193-209. PubMed ID: 22515
[TBL] [Abstract][Full Text] [Related]
6. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
Walker CA
Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
[TBL] [Abstract][Full Text] [Related]
7. A double-blind controlled study of pipothiazine palmitate in the maintenance treatment of schizophrenic outpatients.
Chouinard G; Annable L; Kropsky M
J Clin Pharmacol; 1978; 18(2-3):148-54. PubMed ID: 24061
[TBL] [Abstract][Full Text] [Related]
8. How schizophrenic patients change during 3 years' treatment with depot neuroleptics.
Dencker SJ; Frankenberg K; Lepp M; Lindberg D; Malm U
Acta Psychiatr Scand; 1978 Feb; 57(2):115-23. PubMed ID: 24982
[TBL] [Abstract][Full Text] [Related]
9. Depot fluphenazine decanoate and enanthate for schizophrenia.
David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
[TBL] [Abstract][Full Text] [Related]
10. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
11. Depot bromperidol decanoate for schizophrenia.
Wong D; Adams CE; David A; Quraishi SN
Cochrane Database Syst Rev; 2004; (3):CD001719. PubMed ID: 15266450
[TBL] [Abstract][Full Text] [Related]
12. Depot fluphenazine for schizophrenia.
Adams CE; Eisenbruch M
Cochrane Database Syst Rev; 2000; (2):CD000307. PubMed ID: 10796340
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
